Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Lessin

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
The Journal of Investigative Dermatology|April 1, 1988
DNA-cytophotometry of lymph node touch imprints in cutaneous T-cell lymphomaS R Lessin, G L Grove, L W Diamond, et al.
The Journal of Investigative Dermatology|September 21, 2001
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome)E C Vonderheid, R D Bigler, A Kotecha, et al.
American Journal of Clinical Pathology|June 30, 2000
Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome)L M Galindo, F U Garcia, C A Hanau, et al.
Archives of Dermatology|January 1, 1996
Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implicationsM A Wasik, E C Vonderheid, R D Bigler, et al.
Archives of Dermatology|September 1, 1995
Mycosis fungoides palmaris et plantarisK S Resnik, G R Kantor, S R Lessin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndromeJ T Abrams, S R Lessin, S K Ghosh, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Clinical and Experimental Immunology|January 1, 1997
Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresisA H Rook, S L Gottlieb, J T Wolfe, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
The Journal of Investigative Dermatology|April 1, 1988
DNA-cytophotometry of lymph node touch imprints in cutaneous T-cell lymphomaS R Lessin, G L Grove, L W Diamond, et al.
The Journal of Investigative Dermatology|September 21, 2001
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome)E C Vonderheid, R D Bigler, A Kotecha, et al.
American Journal of Clinical Pathology|June 30, 2000
Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome)L M Galindo, F U Garcia, C A Hanau, et al.
Archives of Dermatology|January 1, 1996
Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implicationsM A Wasik, E C Vonderheid, R D Bigler, et al.
Archives of Dermatology|September 1, 1995
Mycosis fungoides palmaris et plantarisK S Resnik, G R Kantor, S R Lessin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndromeJ T Abrams, S R Lessin, S K Ghosh, et al.
Journal of the American Academy of Dermatology|December 1, 1996
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institutionS L Gottlieb, J T Wolfe, F E Fox, et al.
Clinical and Experimental Immunology|January 1, 1997
Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresisA H Rook, S L Gottlieb, J T Wolfe, et al.
Annals of the New York Academy of Sciences|October 31, 1996
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphomaA H Rook, M Kubin, F E Fox, et al.
Pageof 5